rdf:type |
|
lifeskim:mentions |
umls-concept:C0016384,
umls-concept:C0030705,
umls-concept:C0060389,
umls-concept:C0087111,
umls-concept:C0205070,
umls-concept:C0205474,
umls-concept:C0231175,
umls-concept:C0376358,
umls-concept:C0405581,
umls-concept:C0871261,
umls-concept:C1515985,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
6
|
pubmed:dateCreated |
1998-12-29
|
pubmed:abstractText |
To evaluate the response of testicular androgen ablation in patients with advanced prostate cancer with a biochemical recurrence after finasteride or combined finasteride and flutamide therapy.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0090-4295
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1094-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9836561-Aged,
pubmed-meshheading:9836561-Aged, 80 and over,
pubmed-meshheading:9836561-Androgen Antagonists,
pubmed-meshheading:9836561-Finasteride,
pubmed-meshheading:9836561-Flutamide,
pubmed-meshheading:9836561-Gonadotropin-Releasing Hormone,
pubmed-meshheading:9836561-Humans,
pubmed-meshheading:9836561-Male,
pubmed-meshheading:9836561-Middle Aged,
pubmed-meshheading:9836561-Orchiectomy,
pubmed-meshheading:9836561-Prostate-Specific Antigen,
pubmed-meshheading:9836561-Prostatic Neoplasms,
pubmed-meshheading:9836561-Treatment Failure
|
pubmed:year |
1998
|
pubmed:articleTitle |
Biochemical response to testicular androgen ablation among patients with prostate cancer for whom flutamide and/or finasteride therapy failed.
|
pubmed:affiliation |
Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|